Overgrowth
Gene: NFIX
Sotos syndrome-2 (SOTOS2) is clinically characterized by overgrowth, advanced bone age, macrocephaly, and dysmorphic facial features. Patients develop marfanoid habitus, with long and slender body, very low body mass, long narrow face, and arachnodactyly, with age. Impaired intellectual development and behavior anomalies are present.
Well established gene-disease association.
Marshall-Smith syndrome is allelic. Whole gene deletions, nonsense variants and missense variants affecting the DNA-binding domain have been seen in association with a Sotos-like phenotype (Malan syndrome). Frameshift and splice-site variants thought to avoid nonsense-mediated RNA decay have been seen in Marshall-Smith syndrome.Created: 17 Jan 2021, 7:40 a.m. | Last Modified: 17 Jan 2021, 7:40 a.m.
Panel Version: 0.79
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Sotos syndrome 2, MIM# 614753; Malan syndrome
Publications
Gene: nfix has been classified as Green List (High Evidence).
Phenotypes for gene: NFIX were changed from to Sotos syndrome 2, MIM# 614753; Malan syndrome
Publications for gene: NFIX were set to 33034087; 29897170; 30548146; 25118028
Publications for gene: NFIX were set to 33034087; 29897170; 30548146; 25118028
Publications for gene: NFIX were set to
Mode of inheritance for gene: NFIX was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
gene: NFIX was added gene: NFIX was added to Overgrowth_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: NFIX was set to Unknown